Search

everythinglearnresearchcommunity

for

Search:↓

miR-22 helps skin cancer grow and spread by activating specific cell signals.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Canine epidermal neural crest stem cells could be a promising treatment for spinal cord injuries in dogs.

The erbium-glass laser effectively promotes hair regrowth in alopecia areata.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

CD34-positive cells help repair and form new blood vessels in salivary glands after radiation.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.

Researchers found a new ABCD1 gene mutation linked to a rare brain and nerve disorder with unusual brain changes.

A man developed skin cancer on his scalp after multiple artificial hair grafts.

Platelet-rich plasma can temporarily inhibit some drug-resistant bacteria in diabetic foot infections.

Dermoscopy greatly improves melanoma diagnosis and reduces unneeded surgeries.

Men with hair loss may lack zinc, copper, and vitamin D; supplements could help.

The book reveals diverse patterns of hair growth in different species and advancements in hair and alopecia research.

Fear of hair-related issues causes significant mental distress, especially in high-stress women.